164 related articles for article (PubMed ID: 24277406)
21. Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms.
Taboada R; Claro L; Felismino T; de Jesus VH; Barros M; Riechelmann RP
J Neuroendocrinol; 2022 Apr; 34(4):e13099. PubMed ID: 35174558
[TBL] [Abstract][Full Text] [Related]
22. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
23. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcome of surgical resection in patients with gastroenteropancreatic neuroendocrine neoplasia: results from a German nation-wide multi-centric registry.
Begum N; Maasberg S; Pascher A; Plöckinger U; Gress TM; Wurst C; Weber F; Raffel A; Krausch M; Holzer K; Bartsch DK; Musholt TJ; Keck T; Anlauf M; Rinke A; Pape UF; Goretzki PE;
Langenbecks Arch Surg; 2020 Mar; 405(2):145-154. PubMed ID: 32372309
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
26. [Clinical features and prognostic factors of primary gastric neuroendocrine neoplasms].
Xiong YJ; Liu XY; Cheng CE; Chen C; Sun YB; Tan CH; Liu YT; Feng J; Ma YF; Shi DT; Li R; Tang QY
Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):297-302. PubMed ID: 32209196
[No Abstract] [Full Text] [Related]
27. [Endoscopic diagnosis and treatment of gastrointestinal neuroendocrine neoplasms].
Liu XM; Tuo BG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):854-860. PubMed ID: 34674459
[TBL] [Abstract][Full Text] [Related]
28. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
[TBL] [Abstract][Full Text] [Related]
29. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.
Heetfeld M; Chougnet CN; Olsen IH; Rinke A; Borbath I; Crespo G; Barriuso J; Pavel M; O'Toole D; Walter T;
Endocr Relat Cancer; 2015 Aug; 22(4):657-64. PubMed ID: 26113608
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of diagnosing colorectal neuroendocrine carcinoma using the World Health Organization 2010 classification.
Lee JL; Yu CS; Kim M; Hong SM; Lim SB; Kim JC
Surgery; 2014 Apr; 155(4):650-8. PubMed ID: 24468036
[TBL] [Abstract][Full Text] [Related]
33. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms.
Iwasaki K; Barroga E; Enomoto M; Tsurui K; Shimoda Y; Matsumoto M; Miyoshi K; Ota Y; Matsubayashi J; Nagakawa Y
World J Surg Oncol; 2022 May; 20(1):165. PubMed ID: 35610656
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factor analysis of surgical treatment in patients with rectal neuroendocrine neoplasms].
Wu F; Li P; Zhao H; Liu S; Guo C; Wang Y; Zhao D
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1237-40. PubMed ID: 24924888
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
36. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification.
Endo S; Dousei T; Yoshikawa Y; Hatanaka N; Taniyama K; Yamauchi A; Kamiike W; Nishijima J
Int Surg; 2012; 97(4):335-9. PubMed ID: 23294075
[TBL] [Abstract][Full Text] [Related]
37. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
38. [Neuroendocrine carcinoma of the urinary bladder:clinicopathologic features analysis of 17 cases].
Jiang Y; Yu W; Zhang W; Li Y; Lu Q; Liu Y; Li H; Hou F; Li J; Zhuang J
Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):736-41. PubMed ID: 25582251
[TBL] [Abstract][Full Text] [Related]
39. [Neuroendocrine tumors: analysis of 252 cases].
Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305
[TBL] [Abstract][Full Text] [Related]
40. Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme.
Yin XN; Shen CY; Yin YQ; Chen HJ; Chen HN; Yin Y; Han LY; Chen JJ; Tang SM; Chen ZX; Zhang B
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e37-e44. PubMed ID: 28856815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
